Skip to content
OpenCapital
Get started

Oric Pharmaceuticals, Inc. ORIC Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$1.02B+62.1%
CG Oncology logo
CG OncologyCGON
$5.71B+206%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$1.3B+406%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$982.03M+385%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.93B+436%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0×0.0×
Current ratio16.3×+4.3×

Where this comes from

Computed from the period-end share price: $1.42B.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s market capitalization?
Oric Pharmaceuticals, Inc. (ORIC) reported market capitalization of $1.42B in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
Oric Pharmaceuticals, Inc.'s market capitalization increased by 258.1% year-over-year, from $396.33M to $1.42B.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s market capitalization has grown at a -8.5% compound annual growth rate (CAGR), from $1.24B to $796.64M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.